Background: Tuberculosis is a granulomatous irresistible bacterial infection caused by
Mycobacterium tuberculosis. The present anti-TB antibiotics are less useful in the treatment of Multi-
Drug-Resistant (MDR) strains.
Methods: We focused on distinguishing phyto-bioactive compounds dependent on customary uses
and testing their concentrates against MDR strains. This will help abbreviate the present remedial
regimens for TB and for treating HIV-TB co-disease.
Results: This article is an endeavor to examine the antimycobacterial and immunomodulatory role
of phyto-bioactive compounds as another option and feature them for additional examination for
the management of drug-resistant tuberculosis.
Conclusion: This review focused on the tubercle bacilli utilizing bioactive compounds as the therapeutic
vehicle against MDR strains and also the synergistic action with available TB medications.